Retrospective review of superficial femoral artery stenting in diabetic patients: thiazolidinedione use may decrease reinterventions

@inproceedings{Walker2014RetrospectiveRO,
  title={Retrospective review of superficial femoral artery stenting in diabetic patients: thiazolidinedione use may decrease reinterventions},
  author={Karen L Walker and Daniel B. Walsh and Philip P. Goodney and Samantha A Connell and David Healy Stone and Richard James Powell and Eva M. Rzucidlo},
  booktitle={BMC cardiovascular disorders},
  year={2014}
}
BACKGROUND Diabetics are known to have inferior outcomes following peripheral vascular interventions. Thiazolidinediones are oral diabetic agents which improve outcomes following coronary bare metal stenting. No studies have been performed evaluating thiazolidinedione use and outcomes following lower extremity endovascular interventions. We hypothesize that… CONTINUE READING